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ABSTRACT: 
Abstract word count: 248/250 
Neutrophil elastase (NE) activity is associated with many destructive lung diseases and is a 
predictor for structural lung damage in early cystic fibrosis (CF), which suggests normal 
maintenance of airway epithelium is prevented by uninhibited NE. However, limited data 
exists on how the NE activity in airways of very young children with CF affects function of 
the epithelia. The aim of this study was to determine if NE activity could inhibit epithelial 
homeostasis and repair and whether any functional effect was reversible by antiprotease alpha 
1-antitrypsin (α1AT) treatment. Viability, inflammation, apoptosis and proliferation were all 
assessed in healthy non-CF and CF pediatric primary airway epithelial cells (pAECnon-CF and 
pAECCF respectively) during exposure to physiologically relevant NE. In addition, the effect 
of NE activity on pAECCF wound repair was also assessed. We report that viability after 48 
hours was significantly decreased by 100 nM NE in both pAECnon-CF and pAECCF, due to 
rapid cellular detachment that was also accompanied by inflammatory cytokine release. 
Furthermore, both phenotypes initiated an apoptotic response to 100 nM NE while ≥50 nM 
NE activity significantly inhibited proliferative capacity of cultures. Similar concentrations of 
NE also significantly inhibited wound repair of pAECCF but this was reversed by the addition 
of α1AT. Collectively, our results demonstrate free NE activity is deleterious for epithelial 
homeostasis and supports the hypothesis that proteases in the airway contribute directly to CF 
structural lung disease. It also highlights the need to investigate antiprotease therapies in early 
CF disease in more detail. 
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CF  cystic fibrosis 
CFTR  cystic fibrosis transmembrane conductance regulator 
CT  computed tomography 
ECM  extracellular matrix 
LDH  lactate dehydrogenase 
MMP  matrix metalloproteinase 
NE  neutrophil elastase 
pAEC  primary airway epithelial cell 
ssDNA single-stranded DNA 
UG  Ultroser G 
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INTRODUCTION: 
Cystic fibrosis (CF) is a life-threatening, multi-organ genetic disease that culminates in 
pulmonary failure. Abnormal lung function and structural lung disease are evident as early as 
three months (1). Proteases including neutrophil elastase (NE) and matrix metalloproteinases 
(MMP) are powerful modifiers of tissues and extracellular matrix and have been implicated 
in contributing to structural CF airway disease (2). Present early in CF (3, 4), the argument 
that NE drives lung disease has been further strengthened by observations from the 
Australian Respiratory Early Surveillance Team for CF (AREST CF) program that 
uninhibited NE activity in bronchoalveolar lavage fluid (BALf) from infants is a strong 
predictor for development of bronchiectasis (5). The progressive nature of CF structural lung 
disease (6) suggests an inability of airway tissue to effectively repair in response to chronic 
injury. Thus, identifying and treating the mechanisms of poor airway repair in CF could 
potentially reduce long-term lung morbidity and mortality. 
Although NE has been associated with lung morbidity (7) and the use of BALf has 
significantly improved understanding of pediatric CF lung disease (8), there is paucity of data 
as to whether levels of NE seen in very early CF can sufficiently damage the epithelium, alter 
tissue homeostasis and prevent effective repair. Investigations into the contribution of NE to 
pediatric CF lung disease have been limited due to difficulties in studying airways of infants 
and young children, as well as the multi-factorial nature of established inflammation. Primary 
airway epithelial cell (pAEC) cultures provide an insightful in vitro model of CF epithelial 
physiology and pediatric pAEC from children with mild disease can provide an ideal culture 
model of naïve CF epithelium, since adolescent and adult CF lungs typically altered feature 
morphology reflecting the established, severe neutrophilic disease (9). However, the majority 
of studies investigating mechanisms of NE damage have employed adult-derived, non-CF 
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epithelial cell lines (10-19) or pAEC derived from adults without CF (16, 18, 20-22). To our 
knowledge, no study has modelled pediatric pAEC exposure to levels of free NE activity that 
reflect early CF disease. 
A routine program of pAEC collection by lower airway brushing of young children with and 
without airway disease, including asthma and CF (23, 24), has successfully allowed 
investigation of wound repair in pediatric inflammatory airway diseases (25-27). The aim of 
the study was to use this primary cell model system to measure repair responses of pAEC 
during concentrations of NE typically found in BALf of young children with CF. The two 
hypotheses that were specifically tested were: (i) the concentration of chronic NE exposure 
seen in early life CF will have a detrimental effect on pAEC function, including viability, 
apoptosis, inflammatory cytokine production and proliferation; (ii) that NE will inhibit 
wound repair of CF pAEC in a manner dependent on protease activity and reversible by 
exogenous inhibition of NE activity by alpha-1 antitrypsin (α1AT). 
Some of the results of these studies have been previously reported in the form of abstracts 
(28, 29). 
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MATERIALS AND METHODS: 397/500 
Please refer to the online supplement for full details of methods. 
Subjects and Cell Isolation  
This study was approved by Human Ethics Committees at the Princess Margaret Hospital for 
Children, Perth, Australia, the Royal Children’s Hospital, Melbourne, Australia and the St 
John of God Hospital, Perth, Australia. As described previously (23, 25, 27), lower airway 
pAECs were collected by bronchial brushing from 9 healthy, non-diseased pediatric controls, 
who were undergoing non-respiratory related elective surgery and 16 young children with CF 
who were participating in their annual clinical assessment including BALf. Subject 
demographics are provided (Supplementary Table 1). Primary cultures were established and 
classified as healthy, non-cystic fibrosis (pAECnon-CF), or cystic fibrosis (pAECCF). 
Immortalized human bronchial epithelial cell lines NuLi-1 and CuFi-1 from adults (ATCC, 
Manassas, VA, USA) were used to optimise all cell experiments performed. Cystic fibrosis 
transmembrane conductance regulator (CFTR) genotype was determined as part of newborn 
screening. Bronchiectasis was detected by computed tomography (CT) and scored as 
previously described (1, 5). Lower respiratory pathogens were detected by clinical 
microbiological culture of BALf at the Princess Margaret Hospital for Children, Perth, 
Australia. NE activity was measured in BALf via a modified enzymatic assay (30).  
 
Epithelial Homeostasis 
The effect of NE on the epithelium was modelled via exposure of pAEC monolayers to 
purified human sputum NE (Elastin Products Company, Owensville, MO, USA). Cell 
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viability, proliferation, apoptosis and wound repair were assessed using both in-house and 
commercial assays, as outlined in the online supplement. 
 
Epithelial Wounding 
To assess wound repair kinetics, linear scratch wounds were created using a commercial 
monolayer wounding kit (31) and wound closure in the presence of NE was calculated 
through image analysis by the accompanying live-cell imaging system (Essen Bioscience, 
Ann Arbor, MI, USA), as outlined in the online supplement. For some experiments, NE 
activity was inhibited by 1 µM α1AT (Athens Research & Technology, Athens, GA, USA) to 
model aerosol antiprotease therapy. 
 
Statistical analysis 
Data were tested for population normality as well as homogeneity of variance by histogram 
plots and D'Agostino-Pearson omnibus test. Normally distributed data are reported as mean 
with ± standard deviation and non-normally distributed data reported as median with 
interquartile range. Tests with appropriate parametric or non-parametric statistical analyses 
were conducted using GraphPad Prism 5, with p values less than 0.05 considered significant. 
Unless noted, experiments were performed in replicate using at least four patients of each 
cohort per experiment. 
 
Page 9 of 56  AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
 10 
 
 
RESULTS: 
Establishment of neutrophil elastase dose range: 
A total of 1,338 BALf samples from 318 children with CF had routinely been assessed for 
free NE activity (Supplementary Table 2). Stratification by age revealed that prevalence of 
NE activity also increased with age, rising from 30.17% in the first year of life to 40.43% by 
age six. Over the same time span, mean free NE activity also increased from 20.24 nM in 
infancy to 116.41 nM by age six. When samples with detectable NE activity were solely 
assessed, a mean concentration of 62.61 nM free NE was measured in the first year and this 
value rose to 284.01 nM at age six. Thus a concentration range of 0-100 nM NE activity was 
deemed relevant for all subsequent in vitro experiments performed. 
 
Attachment and viability: 
Exposure of pAEC monolayers to NE over 48 hours resulted in significant loss of confluence 
and increased cell detachment of viable cells (Figure 1). Compared to control media, 
incubation of both pAECnon-CF and pAECCF with 100 nM NE resulted in a more spherical 
cellular morphology that was paralleled by significant detachment off the culture surface 
(Figure S1). Even as early as 12 hours of exposure to 100 nM NE, loss of confluence was 
significant for both pAECnon-CF (p<0.01; Figure 1A) and pAECCF (p<0.05; Figure 1B) and 
this was maintained for the duration of the experiment. No significant morphological changes 
were observed for either phenotype at lower concentrations of NE. The number of viable 
attached cells in the monolayer was subsequently assessed by MTS colorimetric assay. When 
compared to control media, exposure to 100 nM NE resulted in a significant reduction in cell 
viability (Figure 1C) of both pAECnon-CF (21.62% of control, p<0.001) and pAECCF (40.02% 
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of control, p<0.05). However, there was no significant difference in the reduced viability 
between pAECnon-CF and pAECCF (p=0.4347). Due to the significant loss of attachment, 
cellular viability was further investigated by measuring lactate dehydrogenase (LDH), a 
marker of cytotoxicity. There was a significant increase in supernatant LDH levels following 
48 hour exposure to 100 nM NE for pAECnon-CF (p<0.01; Figure 1D), but not for pAECCF. 
Furthermore, there was no significant difference in LDH levels between pAECnon-CF and 
pAECCF supernatant. When primary cells were compared to their equivalent cell lines, 
confluence measurements did not change over 48 hours for either NuLi-1 (Figure S2A) or 
CuFi-1 (Figure S2B) and suggested a reduced susceptibility to NE. There was also no 
significant change in viability (Figure S2C) or LDH production (Figure S2D) for either NuLi-
1 or CuFi-1 when exposed to any concentration of NE. 
 
Apoptosis: 
Since no significant increase in cell cytotoxicity was observed to accompany the change in 
morphology and cell detachment, pAEC were then assessed for an apoptotic response to NE. 
Apoptosis was induced (2.48 ±0.86 fold change over untreated) as early as three hours in 
pAECnon-CF when exposed to 100 nM NE (Figure 2A; p<0.01) and reached a peak of 3.50 
±1.79 fold change at 12 hours (p<0.05). In comparison, apoptosis in pAECCF was induced to 
a lesser extent by 100 nM NE with a significant apoptotic response (2.01 ±0.65 fold change 
over untreated) only seen at 6 hours incubation (Figure 2B; p<0.05). Although data suggested 
a lower apoptotic response in pAECCF, it was not significantly different to pAECnon-CF at any 
time point assessed. Compared to their primary cell counterparts, no significant induction of 
apoptosis was observed for either NuLi-1 or CuFi-1 when exposed to similar concentrations 
of NE (data not shown). 
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Inflammatory cytokine production: 
To investigate the relationship between NE exposure and inflammation, sentinel pro-
inflammatory cytokines, IL-6 and IL-8 were measured in supernatants collected following the 
viability and apoptosis experiments (Figure 2C & 2D). There was no significant increase in 
IL-6 production by pAECnon-CF after exposure to any of the NE concentrations assessed 
(Figure 2C). However, pAECnon-CF produced significantly more IL-8 in response to 100 nM 
NE (145.26 ±85.26 ng/mL/viable cells, p<0.01) compared to controls (55.16 ±21.45 
ng/mL/viable cells). In contrast, exposure of pAECCF to 100 nM NE significantly increased 
IL-6 (32.08 ±18.19 vs 13.47 ±8.20 ng/mL/viable cells, p<0.05) and IL-8 production (183.30 
±127.60 vs 67.47 ±39.84 ng/mL/viable cells, p<0.05) compared to controls. When IL-6 and 
IL-8 levels were compared between disease phenotype, no differences were observed. When 
primary cell cultures were compared to cell lines, no significant induction of either IL-6 or 
IL-8 was observed for NuLi-1 or CuFi-1 when exposed to similar concentrations of NE (data 
not shown). 
 
Proliferation: 
Having established that exposure to free NE decreased pAEC viability, the effect on 
proliferation was assessed by counting cell number after 120 hour incubation and measuring 
viable cell number by MTS assay. When exposed to 10 nM NE, both pAECnon-CF and 
pAECCF exhibited normal pAEC morphology and confluence increased over 120 hours 
(Figures 3A & 3B, S3 & S4). Interestingly, 50 nM NE inhibited this increase in confluence of 
both pAECnon-CF (0.92 ±0.21 vs 2.12 ±0.55 fold, p<0.05; Figure 3A & S3) and pAECCF (1.10 
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±0.27 vs 2.23 ±0.44, p<0.01; Figure 3B & S4), despite no apparent changes in cell 
morphology or attachment. Furthermore, no cell growth was observed when cells were 
exposed to 100 nM NE (Figure 3C) and final cell number of both phenotypes was 
significantly reduced in comparison to control media (pAECnon-CF 13.51 ±2.44 vs 5.23 ±2.09 
x 10
5
 cells, p<0.05; pAECCF 10.86 ±2.47 vs 5.19 ±0.91 x 10
5
 cells, p<0.05). Viable cell 
number after 120 hours also agreed with the confluence and cell number measurements 
(Figure 3D). Incubation with either 50 or 100 nM NE, significantly reduced the number of 
viable pAECnon-CF and pAECCF when compared to controls (50 nM p<0.01; 100 nM 
p<0.001). Overall, a dose-dependent inhibition of proliferation was observed for both 
pAECnon-CF and pAECCF, whereby 50 nM NE inhibited proliferation, while 100 nM abolished 
both attachment and proliferation of pAEC. In cell lines, both NuLi-1 and CuFi-1 were able 
to maintain attachment even in response to 100 nM NE with no significant change in 
morphology (data not shown). In addition, no significant effect on proliferation was seen 
after exposure to any concentration of NE assessed (Figure S5A-S5C). 
 
Wound Repair: 
Since NE is not typically detectable in healthy lungs where injury and inflammation is 
minimal, wound repair experiments were performed only in pAECCF. Exposure of wounded 
pAECCF monolayers to NE over 72 hours resulted in significantly delayed or inhibited repair 
(Figure 4). In non-NE exposed controls, rapid migration of cells into the denuded area was 
seen, with 50.30% ±18.04 of the wounded area confluent by 12 hours. Complete closure 
occurred at approximately 48 hours post wounding. There was no apparent effect on repair 
kinetics following exposure to 10 nM NE. In contrast, exposure to 100 nM NE significantly 
reduced closure to 15.45% ±6.62 (p<0.01) by 12 hours. Cells exhibited rounded-up spherical 
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morphology and loss of attachment was observed in the non-wounded areas. Loss of adhesion 
was seen to persist for the period of incubation with NE. Passive migration of detached pAEC 
into the wound area through Brownian motion was limited by employing an automated, 
incubated microscope that eliminated plate movement. Resulting data for 100 nM NE 
exposure demonstrated that wound closure was incomplete at 21.48% ±6.90 by 72 hours 
(Figure 4; p<0.05). A dose-dependent effect on repair was apparent, since 50 nM NE activity 
did not reduce attachment but did result in a slower repair rate, with wound closure at 30 
hours significantly less (65.88% ±15.59) than controls (85.14% ±10.81; p<0.05). However, 
repair was not completely inhibited but rather delayed, as wounds achieved full closure by 72 
hours (Figure 4). In contrast to the primary cell data, 100 nM NE only delayed wound repair 
of CuFi-1 cells (Figure S7) up to 42 hours post-wounding (p<0.05) and complete repair was 
still achieved by 72 hours. 
 
NE Inhibition and Wound Repair 
Having established that certain concentrations of free NE inhibited wound closure of 
pAECCF, the addition of NE inactivators such as α1AT was investigated. Due to the 
significant reduction in wound closure, as well as morphological changes, after 12 hours 
exposure to 100 nM NE (Figure 4), this time point was selected for the addition of 1 µM 
α1AT. Cell morphology and wound closure was not affected by 1 µM α1AT (Figure 5A), 
either at 30 hours (91.42% ±7.63 closure in 1 µM α1AT  vs 85.14% ±10.81 in control media, 
p=0.3194) or 72 hours (99.57 ±0.97 closure in 1 µM α1AT  vs 100.00 ±0.71 in control media, 
p=0.4428). When 1 µM α1AT was added at 12 hours to pAECCF exposed to 100 nM NE, 
morphological and cell count assessment indicated cell attachment was restored (Figure S6). 
Closure at 30 hours post wounding by pAECCF initially exposed to 100 nM NE and then 
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treated with 1 µM α1AT was significantly increased over 100 nM NE alone (38.48% ±10.03 
closure in 100 nM NE and 1 µM α1AT vs 20.22% ±6.55 in 100 nM NE and no α1AT, 
p<0.05; Figure 5B). Repair continued over the duration of the experiment, with a mean 
wound closure at 72 hours more than four-fold higher than cells not treated with α1AT 
(79.94% ±17.50 closure in 100 nM NE and 1 µM α1AT vs 21.48% ±6.90 in 100 nM NE and 
no α1AT, p<0.001). Despite this improvement, wound closure at 72 hours for cells exposed 
to 100 nM NE and 1 µM α1AT still remained significantly lower than for pAECCF in control 
media alone (79.94% ±17.50 closure in 100 nM NE and 1 µM α1AT vs 100.00% ±0.71 in 
control media, p<0.05; Figure 5B). For pAECCF exposed to 50 nM NE, addition of 1 µM 
α1AT also significantly increased repair at 24 hours compared to 50 nM NE alone (71.91% 
±7.70 closure in 50 nM NE and 1 µM α1AT vs 56.51% ±13.59 in 50 nM NE and no α1AT, 
p<0.05). At 30 hours post wounding, closure was still significantly higher than for untreated 
cells (83.94% ±10.63 closure in 50 nM NE and 1 µM α1AT vs 65.88% ±15.59 in 50 nM NE 
and no α1AT, p<0.05) and was not significantly lower than pAECCF in control media 
(p=0.6716). Interestingly CuFi-1 cells failed to recapitulate the improved repair seen in 
primary cells after addition of 1 µM α1AT (Figure S7). 
 
Assessment of viable cell number at the end of wound closure experiments demonstrated that 
100 nM NE led to a reduced viable cell number (14.19% ±7.07, p<0.001; Figure 6) compared 
to controls. After 72 hours incubation with α1AT, pAECCF viable cell number was 
significantly increased when 1 µM α1AT was added at 12 hours (71.95% ±11.55, p<0.001), 
suggesting cellular detachment. However, viable cell number following α1AT treatment was 
still lower than pAECCF in control media alone (p<0.05). There was no significant effect of 
α1AT on viable cell number for any of the lower NE concentrations assessed.
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DISCUSSION: 
This study investigated the response of pAEC cultures derived from pediatric patients with 
CF to concentrations of NE activity found in the airways and provides the first direct 
evidence that free NE adversely affects epithelial repair following injury  We 
comprehensively assessed the effect of NE purified from human CF sputum on the processes 
essential for epithelial homeostasis, namely; attachment, viability, apoptosis, proliferation 
and wound repair. Our data indicated that free NE activity was significantly deleterious for 
all of these processes, at relatively low concentrations found in BALf from infants with CF. 
Specifically, we found NE reduced both attachment and proliferation of pAEC, induced 
apoptosis and also inhibited the ability of cell culture monolayers to repair a scratch wound. 
Of significance was that subsequent addition of α1AT mitigated the inhibitory effect of NE 
on reparative capacity, suggesting a potential therapeutic role for antiproteases in preventing 
tissue damage. This is the first age-relevant data to demonstrate that free NE activity impairs 
both homeostasis and wound repair of pAEC monolayers, further reinforcing a role for NE in 
the development of structural CF lung disease during infancy. 
 
In order to identify concentrations of NE activity relevant to the early CF airway, we 
analysed a large, longitudinal cohort of more than 1,300 BALf samples. Overall, ~33% of 
BALf samples had free NE detected and within the first year of life, prevalence was ~30% 
with a mean NE activity of 62.61 nM. Although slightly lower than the 38-56% prevalence 
reported elsewhere (3, 4, 32), this is the first, unselected total cohort study reported. Both 
prevalence and mean level of NE activity was found to increase with age. Large variations in 
NE activity were also observed, with micromolar concentrations of activity in some samples 
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that approached adolescent and adult CF sputum levels (33, 34). Our analysis provides novel 
evidence that nanomolar NE activity is common in infants with CF and progressively 
increases with age despite best practice care.  Given the pleiotropic effects of NE on 
biological systems, an increasing impact on epithelial homeostasis during childhood is likely. 
 
Adhesion of epithelial cells to the extracellular matrix (ECM) structure and neighbouring 
cells is critical to maintaining epithelial barrier integrity. Free NE is able to digest a wide 
range of ECM molecules and our study found 100 nM NE activity reduced both attachment 
and viability in both pAECnon-CF and pAECCF phenotypes. Exposure to NE significantly 
reduced monolayer confluence by 12 hours and less than 40% of cells remained attached by 
48 hours. Cellular detachment in response to NE exposure has been reported elsewhere (12) 
however in that study, 80% detachment of A549 cells was only induced by 10 µg/mL (339 
nM) NE, a concentration three-fold higher than required here for 80% detachment of pAEC 
(12). In addition, two other studies have described detachment of 16HBE14o
-
 or BET-1A cell 
lines by 100 nM NE but detachment was not quantified (11, 14). Others have reported no 
disruption to monolayers of primary human tracheal epithelial cells by concentrations of NE 
lower than 10 µg/mL (20), or not assessed NE concentrations similar to our study (13, 17).  
Overall, our investigation illustrated that pAEC from young airways demonstrate an 
increased sensitivity to NE activity compared to these adult cells investigated elsewhere. 
 
Apoptosis was also induced when pAEC were exposed to NE. This agrees with previous data 
(16-18), where approximately two-fold increases in apoptosis were observed in epithelial 
cells after four hours exposure to NE. A proposed mechanism is proteolytic activation of 
proteinase-associated receptor-1 (PAR-1), triggering the caspase-9 apoptotic pathway (16, 
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18). Interestingly, our data reported the apoptotic response by pAECCF to NE plateaued at 6 
hours and was dampened in comparison to the response by pAECnon-CF, which peaked at 12 
hours post-exposure. Dampened apoptotic responses to viral infection by pAECCF have been 
reported previously by our group (27), suggesting reduced apoptotic responses are inherent to 
CF and may have important implications for CF respiratory disease, such as increased 
damage and an excessive pro-inflammatory response by the epithelium following insults. 
However, viral induction of apoptosis was not assessed in this study and future studies 
comparing both viral and protease induced apoptosis, whilst employing a wider array of 
apoptosis assays, may identify the defects in CF apoptotic pathways. After 48 hours exposure 
to NE, a small but significant increase in pAECnon-CF supernatant levels of LDH was observed 
with a similar but non-significant trend in pAECCF supernatant. Whether increased 
cytotoxicity is due to the long exposure to NE is not known, since the one previous study in 
the literature that measured cytotoxicity only assessed a 30 minute exposure and found no 
increase in LDH (19). However, future time-course studies comparing apoptotic and 
cytotoxic responses could be informative on how persistent free NE activity in airways 
contributes to the CF inflammatory cycle through these processes (35). Overall, our data 
supports the concept that development of free NE activity initially drives an apoptotic, rather 
than necrotic, response in pediatric airway epithelium. 
 
A pro-inflammatory response to 100 nM NE resulted in significantly increased IL-8 
production by pAEC from healthy and CF cohorts, with a similar trend observed for IL-6. 
There are a number of studies that report NE concentrations as low as 10 nM inducing IL-8 
production in both adult primary (21, 22) and epithelial cell lines (10, 11, 14). The lack of 
concordance at lower concentrations between the data presented here and the literature could 
be due to certain studies assessing cytokine mRNA rather than protein (12). In addition, the 
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longer exposure of 48 hours in our study could have led to IL-8 degradation by NE, as 1 
µg/mL (33.9 nM) NE has been shown to degrade IL-8 over 24 hours via proteolysis (36). 
 
The most evident dose dependent effect of NE was on pAEC proliferation, with 100 nM NE 
significantly preventing proliferation when measured by either total or viable final cell 
number. Although cellular detachment by 100 nM NE is a possible confounder when 
interpreting viable cell number data, the measured lack of increase in final cell number from 
the initial seeding amount, as well as an accompanying lack of increase in monolayer 
confluence, corroborates our experimental interpretation that cellular proliferation could be 
reduced in airways with free NE activity. Inhibiting proliferation in vivo would limit the pool 
of cells available for epithelial homeostasis, repair and tissue turnover. Previous studies 
assessing NE and airway cell proliferation have been restricted to cell lines, with one study 
demonstrating cell cycle inhibition of NHBE’s (37) whilst elsewhere ≥40 nM NE activity 
increased both 3H uptake and cell counts of the A549 cell line (38). Conflicting data in the 
literature may be due to biological differences, since in our study NE inhibited pAEC 
proliferation but had no observable effect on NuLi-1 or CuFi-1 proliferation. Altered cellular 
metabolism and increased resistance to NE-dependent cellular detachment by cell lines may 
explain their failure to recapitulate the pAEC data presented here. 
 
Few studies have assessed airway cell wound repair in the presence of NE. One study 
reported that 0.03 Units/mL NE (20 nM NE) or greater inhibited wound closure of the cell 
line 16HBE14o
-
 by approximately 50% at 13 hours (19). Another study observed no 
inhibition of repair by the functionally related, keratinocyte skin epithelial cell after 9 hours 
incubation with 34 nM NE (39). Both of these studies only assessed wound closure at a single 
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time point. In contrast, our study assessed wound repair over 72 hours and data supported our 
hypothesis that nanomolar concentrations of NE can reduce epithelial repair. Incubation with 
50 nM free NE activity significantly delayed pAECCF repair, although wound closure was 
completed by 72 hours. However, 100 nM completely abolished repair due to the significant 
detachment that occurred by 12 hours. Together, these findings suggest that free NE might 
prevent effective epithelial repair responses following injury in vivo and further implies a 
mechanistic role for NE in the formation of structural lung disease. Whether the effect over 
extended periods are due to NE exposure itself or a possible secondary effect induced by the 
original insult, is currently unknown and requires further investigation. 
 
A novel and important critical finding from our study is that inhibited pAECCF repair could 
be rescued by inhibition of NE activity following initial exposure. Addition of α1AT, even 
after 12 hours exposure to 50 nM NE that was enough to significantly delay repair, restored 
wound closure by pAECCF to control levels by 30 hours. Also reversed by α1AT was the loss 
of adhesion due to 100 nM NE, resulting in reattachment and significantly increased wound 
closure by 72 hours. Although inhibition of NE has not been investigated in the context of 
pAEC repair, other studies have demonstrated that proteolytic-associated detachment of cells 
can be inhibited by protease inhibitors α1AT, SLPI and elafin (40, 41), indicating that 
inhibiting proteolytic activity of NE should be the therapeutic aim.  Our study assessed α1AT 
as it is the major host antiprotease and is a therapy with a long track record, having been 
employed in various formats since 1988 to treat individuals with α1AT deficiency (42). More 
recently, α1AT received orphan drug designation for use as an aerosol therapy in adults with 
CF following several promising pre-clinical trials on deposition and protease inhibition (33, 
43, 44). From the results presented here we speculate that targeted inhibition of free NE 
activity in very early CF disease may have a rapid and significant positive effect on epithelial 
Page 20 of 56 AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
 21 
 
homeostasis. Synthetic inhibitors of NE are now available e.g., Sivelestat and AZD9668 that 
also possess potential for use in CF, although Sivelestat is only approved in Japan for clinical 
use in acute lung injury and clinical trial data reported limited efficacy for AZD6998 in 
COPD (45, 46).  
 
Recent findings are now highlighting additional pathways through which uncontrolled NE 
activity can induce lung damage in CF, in particular the dysregulation of MMP activity by 
NE (2, 47). Dysregulated MMP-9 activity is associated with deficient wound repair, further 
mucous hypersecretion and airway remodelling in many airway diseases including CF (48) 
and excess MMP-1 and MMP-12 activation by NE can lead to α1AT degradation that may 
prolong the cycle of excess NE activity and destruction (49). Therefore, chronic activation of 
these powerful modifiers of tissues and extracellular matrix by NE may be equally important 
to CF disease. Currently there are no MMP inhibitors approved and thus inhibiting upstream 
NE activity may present the most direct therapy available to prevent protease driven lung 
damage. To address these hypotheses, future studies are planned to address the relationship 
between NE and MMPs during repair of pAEC in vitro and the early stages of in vivo CF 
lung disease. 
 
In summary, our data supported our hypotheses and suggest that free NE activity is 
deleterious for epithelial homeostasis, reducing adhesion and increasing apoptosis with an 
accompanying pro-inflammatory stimulation. Restoration of the airway epithelium during CF 
disease may also be restricted by NE. Thus, free NE is able to induce multiple cellular 
responses in the epithelium that could contribute to CF respiratory disease during early life. 
Studies using chest CT have identified a strong link between bronchiectasis and free NE 
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activity in infancy (1, 5) and observations reported here at NE concentrations lower than what 
can be detected in the paediatric CF airway, are consistent with protease activity in the airway 
contributing directly to CF structural lung disease. Therefore, a logical consideration is for 
clinical trials of antiprotease therapies in very young children with CF. 
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Figure 1: Effect of free NE on confluence and viability in pAECs. Monolayer cultures of 
pAEC were exposed to NE over 48 hours and then cell confluence, viability and cytotoxicity 
assessed. No change in confluence by pAECnon-CF (A) and pAECCF (B) was observed for 
control media (circles), 10 nM (squares) or 50 nM (triangles) NE over 48 hours. In contrast, 
100 nM NE (diamonds) significantly reduced monolayer confluence as early as 12 hours. 
Assessment of cellular viability by MTS assay (C) demonstrated that cell number of both 
pAECnon-CF (open bars) and pAECCF (closed bars) was significantly decreased in response to 
100 nM NE, compared to respective controls. LDH production represented as a fold change 
over untreated (D) was significantly induced in pAECnon-CF (open bars) by 100 nM NE, but 
did not reach significance for pAECCF (closed bars). Data was obtained from four to eight 
separate experiments, with each point in duplicate. *Indicates p<0.05 for 100 nM NE. 
 
Figure 2: Effect of free NE on apoptotic induction and inflammatory cytokine 
production in pAEC. Monolayer cultures of pAECnon-CF (A) and pAECCF (B) were exposed 
to 10 nM (squares), 50 nM (triangles) and 100 nM (diamonds) NE over 48 hours and 
apoptosis assessed at 3, 6, 12, 24 and 48 hours by ssDNA formation. Results were then 
represented as a fold change over control media. Exposure of pAECnon-CF to 100 nM NE 
significantly induced apoptosis as early as three hours and this remained significantly higher 
by 24 hours (A). Apoptosis was also seen in pAECCF exposed to 100 nM NE, although this 
was only significant at 6 hours (B). No significant change was observed for either 10 or 50 
nM NE. Supernatants were also assessed by ELISA to measure IL-6 (C) and IL-8 production 
(D). IL-6 productionwas significantly higher in pAECCF (closed bars) treated with 100 nM 
NE, while IL-8 production was significantly higher for both pAECnon-CF (open bars) and 
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pAECCF (closed bars). Data was obtained from four to eight separate experiments, with each 
point in duplicate. *Indicates p<0.05 for 100 nM NE. 
 
Figure 3: Effect of free NE on cell proliferation in pAECs. pAEC were seeded  at 5,000 
cells/well and incubated for 24 hours to facilitate attachment. Cells were then exposed to NE 
over 120 hours and proliferation was assessed. Confluence of pAECnon-CF (A) and pAECCF 
(B) increased in response to both control media (circles) and 10 nM NE (squares). However, 
confluence remained static or decreased in the presence of 50 nM (triangles) and 100 
(diamonds) nM NE respectively. After 120 hours, cell number was determined through cell 
counting of time-lapse images (C). Final cell number of pAECnon-CF (open bars) and pAECCF 
(closed bars) was significantly lower for 100 nM NE compared to control media. Subsequent 
assessment of cell viability by MTS (D) demonstrated 50 nM and 100 nM NE significantly 
reduced final viable cell number of pAECnon-CF (open bars) and pAECCF (closed bars) in 
comparison to control media. Data was obtained from four separate experiments, with each 
point performed in quadruplicate. *Indicates p<0.05 to control. 
 
Figure 4: Effect of free NE on pAECCF wound repair. Confluent pAECCF monolayer 
cultures were scratch wounded and repair in the presence of NE observed and quantified. In 
control media (circles) and 10 nM NE (squares), pAECCF achieved 85% closure by 30 hours 
post wounding and 100% by 54 hours. However, 50 nM NE (triangles) significantly reduced 
wound closure at 30 hours. A more pronounced effect on repair was observed for 100 nM NE 
(diamonds), with significantly reduced wound closure observed at 12 hours that remained 
over 72 hours. *Indicates p<0.05 to control media, dotted line represents mean closure of 
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pAECCF at 30 hours in control media. Data was collated from five separate experiments, with 
each point performed in triplicate. 
Figure 5: Effects of α1AT on NE inhibited pAECCF wound repair. (A) Confluent 
monolayer cultures of pAECCF were scratch wounded and repair observed in the presence of 
α1AT (half closed circles). No significant difference in wound repair by pAECCF in control 
media (closed circles) was seen following addition of 1 µM α1AT (half closed circles). (B) 
Repair of scratch wounded cultures was also assessed in the presence of 50 nM (closed 
triangles) and 100 nM NE (closed diamonds). At 12 hours post wounding, 1 µM α1AT was 
added to a number of wells to inhibit free NE (50 nM and 100 nM NE). Treatment of 
pAECCF exposed to 50 nM NE with α1AT (half closed triangles) significantly improved 
wound closure at 30 hours to levels and were similar to controls. Furthermore, repair of 
pAECCF exposed to 100 nM NE and α1AT (half closed diamonds) was also significantly 
increased by 30 hours and closure continued through to 72 hours. *Indicates p<0.05 to NE 
without α1AT treatment, dotted line represents mean closure of pAECCF at 30 hours in 
control media. Data was collated from five separate experiments, with each point performed 
in triplicate.  
 
Figure 6: Effect of α1AT treatment on viable cell number. Confluent monolayer cultures 
of pAECCF were scratch wounded and repair in the presence of NE observed. At 12 hours 
post wounding, 1 µM α1AT was added to a number of wells to inhibit NE. After a further 72 
hours, viability of pAECCF exposed to NE alone (closed bars) and pAECCF treated with α1AT 
at 12 hours (striped bars) was measured by MTS assay. Exposure of cells to 100 nM NE 
significantly reduced viable cell number, but this was significantly increased by α1AT 
treatment. However, viable cell number remained significantly lower than control. *Indicates 
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p<0.05 to control, 
#
indicates p<0.05 to 100 nM NE alone. Data was collated from five 
separate experiments, with each point performed in triplicate. 
Page 30 of 56 AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
  
 
 
 
170x127mm (300 x 300 DPI)  
 
 
Page 31 of 56  AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
  
 
 
 
181x145mm (300 x 300 DPI)  
 
 
Page 32 of 56 AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
  
 
 
 
184x146mm (300 x 300 DPI)  
 
 
Page 33 of 56  AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
  
 
 
 
83x57mm (300 x 300 DPI)  
 
 
Page 34 of 56 AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
  
 
 
 
174x252mm (300 x 300 DPI)  
 
 
Page 35 of 56  AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
  
 
 
 
92x62mm (300 x 300 DPI)  
 
 
Page 36 of 56 AJRCMB Articles in Press. Published on 29-July-2015 as 10.1165/rcmb.2015-0074OC 
 Copyright © 2015 by the American Thoracic Society 
  
ONLINE DATA SUPPLEMENT
 
Alpha 1-antitrypsin mitigates the inhibition of airway epithelial cell repair by 
neutrophil elastase 
Luke W Garratt, Erika N Sutanto, Kak-Ming Ling, Kevin Looi, Thomas Iosifidis, Kelly M 
Martinovich, Nicole C Shaw, Alysia G Buckley, Elizabeth Kicic-Starcevich, Francis J 
Lannigan, Darryl A Knight, Stephen M Stick & Anthony Kicic on behalf of AREST CF 
 
MATERIALS AND METHODS: 
Reagents 
The following reagents were sourced for this study. Bovine pituitary extract, recombinant 
human epidermal growth factor, epinephrine hydrochloride, hydrocortisone, insulin, 
methanol, N-methyl-2-pyrrolidone, N-methoxysuccinyl Ala-Ala-Pro-Val p-nitroanilide, all 
trans retinoic acid, transferrin, triiodothyronine, Trizma base, Trizma hydrochloride and 
trypsin were purchased from Sigma-Aldrich (St Louis, MO, USA). Amphotericin B, fetal 
bovine serum (FBS), gentamicin, penicillin/streptomycin and RPMI-1640 media were 
purchased from Invitrogen (Melbourne, Victoria, Australia). Collagens S (type I) as well as 
fibronectin were purchased from Roche (Sydney, New South Wales, Australia). Bronchial 
epithelial basal medium (BEBM) was purchased from Lonza (Basel, Switzerland). Ultroser G 
was purchased from Pall Biosepra (Cergy-Saint Christophe, France). All plasticware was 
purchased from In Vitro Technologies (Melbourne, Victoria, Australia), except for 96 well 
Essen ImageLock plates from Millenium Science (Melbourne, Victoria, Australia). Purified 
human sputum neutrophil elastase (NE) for in vitro cell exposure was purchased from Elastin 
Products Company (Owensville, MO, USA), purified human blood NE for the assessment of 
NE activity in BALf as previously described (E1, E2) was purchased from Calbiochem 
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(Darmstedt, Germany). Purified human plasma alpha-1 antitrypsin was purchased Athens 
Research Technology (Athens, GA, USA). 
 
Cell culture 
Primary cultures were plated into tissue culture vessels pre-coated with fibronectin (10mM), 
collagen (30mM) and bovine serum albumin (100mM) and expanded unmodified as previous 
described (E2, E3). Bronchial epithelial growth medium (BEGM) was used for all cell culture 
and consisted of bronchial epithelial basal medium (BEBM), supplemented with 50 µg/ml 
bovine pituitary extract, 25 ng/ml recombinant human epidermal growth factor (EGF), 0.5 
µg/ml epinephrine hydrochloride, 0.5 µg/ml hydrocortisone, 5 µg/ml insulin, 0.1 ng/ml all 
trans retinoic acid, 10 µg/ml transferrin and 6.5 ng/ml triiodothyronine, 0.125 µg/ml 
amphotericin B, 50 µg/ml gentamicin, penicillin/streptomycin (10 Units/mL penicillin and 
0.01 mg/mL streptomycin) and 2% (v/v) Ultroser G. Established cultures were fed every 
second day and were passaged every 14-21 days with 0.25% Trypsin/0.05% EDTA, with 
experimental assays performed at passages one or two. 
NuLi-1and CuFi-1 cells (CRL-4011 and CRL-4013, ATCC, Manassas, VA, USA) are 
bronchial epithelial cells derived from normal and CF human lung respectively, transformed 
using human telomerase reverse transcriptase (hTERT) and human papillomavirus type 16 E6 
and E7 genes (E4). Bronchial epithelial growth medium (BEGM) was used for all cell culture 
and tissue culture vessels were pre-coated with fibronectin (10mM), collagen (30mM) and 
bovine serum albumin (100mM). Established cultures were fed every second day and were 
passaged every 5-7 days with 0.25% Trypsin/0.05% EDTA, with experimental assays 
performed between passages four and nine. 
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Assessment of viablity 
Cell viability and proliferation was evaluated using the CellTiter 96 MTS (3-(4,5-
dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner 
salt) assay, which is based on the reduction of the tetrazolium salt to a formazan product by 
mitochondrial dehydrogenases of living cells (Promega, WI, USA) (E5). Results were 
interpreted as formazan product formation compared to controls. 
To evaluate the effect of NE on epithelial monolayers, cell cultures were maintained in 
BEGM on 96-well microtitre plate until >95% confluent. A dose range of 0 nM to 100 nM 
NE was made in 200 µL EGF-free BEGM with 0.5% (v/v) UG and incubated over 48 hours 
at 37°C. Phase contrast time-lapse images were taken every two hours using an IncuCyte 
live-cell imaging system (Essen Bioscience, Ann Arbor, MI, USA). Cell supernatants were 
retained at the end of the experiment and stored at -80°C for down-stream assessment. Wells 
were washed once with serum-free clear RPMI-1640 before the MTS assay was performed in 
serum-free clear RPMI-1640 (E6). Plates were left to incubate for 2 hours at 37ºC degrees 
and finally read on a Multiskan FC spectrophotometer (Thermo Fisher Scientific, Melbourne, 
VIC, Australia) at a wavelength of 490 nm.  
To evaluate the effect of NE on epithelial proliferation, cells were seeded aseptically into a 
96-well microtitre plate at a density of 5,000 cells per well and maintained overnight at 37°C 
to ensure attachment. This density was shown previously to yield an exponential growth 
phase of cells over a 5 day time period (data not shown). A dose range of 0 nM to 100 nM 
NE was made in 200 µL EGF free BEGM with 0.5% (v/v) UG, and plates incubated over 5 
days at 37°C. Phase contrast time-lapse images were taken every two hours using an 
IncuCyte live-cell imaging system (Essen Bioscience, Ann Arbor, MI, USA). After 3 days, 
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media was carefully refreshed by two thirds volume. After 5 days incubation, wells were 
washed once with serum-free clear RPMI-1640 before MTS assay was performed. In addition 
to viability assessment, proliferation was also measured as final total cell number, which was 
obtained by manual counting of cells in images taken at 120 hours. 
Cell viability and proliferation results were complemented by assessment of cellular 
confluence, recorded through image analysis by the IncuCyte software (Essen Bioscience, 
Ann Arbor, MI, USA) and interpreted as a fold change from the first image. 
 
Assessment of apoptosis 
Apoptosis was assessed using a single-stranded DNA (ssDNA) apoptosis kit (Millipore, 
Billerica, MA, USA) as previously described (E3), which measures apoptotic cells through 
formamide denaturation and antibody detection of ssDNA (E7). Briefly, assays were 
performed in a 96-well microtitre with cells seeded at a density of 20,000 cells per well. A 
dose range of 0 nM to 100 nM NE was made in 200 µL EGF free BEGM with 0.5% (v/v) 
UG, and plates incubated over 5 days at 37°C. At 3, 6, 12, 24 and 48 hours, supernatant was 
carefully collected to prevent cell removal before the monolayer was fixed at room 
temperature for 30 minutes with 200 µL of 80% (v/v) methanol in PBS. Following fixation, 
plates were air-dried overnight in a laminar flow hood to ensure adherence of all cells. 
Formamide incubation denatured DNA in apoptotic cells only, permitting antibody binding of 
ssDNA that was subsequently quantified with plates read at a wavelength of 405 nm on a 
Multiskan FC spectrophotometer. A negative control was provided by DNase incubation to 
ensure antibody specificity, and a well coated with ssDNA used as positive control. Results 
were represented as fold change in signal over cells exposed to control media as directed by 
the manufacturer 
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Assessment of cytotoxicity 
Cellular cytotoxicity was quantified via the CytoTox 96 colorimetric assay (Promega, 
Madison, WI, USA) as previously described (E3), which measures the amount of lactate 
dehydrogenase (LDH) release due to necrotic cell lysis. LDH is a large intracellular molecule 
which is unable to cross the cell membrane (E8). Briefly, stored supernatant from the 
viability and apoptosis experiments were thawed, mixed with CytoTox 96 Substrate Mix and 
incubated for 30 minutes at RT, protected from light. The enzymatic reaction was then 
stopped with CytoTox 96 Stop Solution and colour change was measured using a Multiskan 
FC spectrophotometer at 490 nm. Results were interpreted as a fold change from control. 
 
Assessment of wound repair 
The ability of airway epithelial cells to repair wounds following NE exposure was assessed 
by scratch wounding and image analysis, as described previously (E9). Briefly, pAECCF 
cultures were maintained in BEGM on 96 well ImageLock tissue culture plates until >95% 
confluent. Using a WoundMaker device (Essen Bioscience, Ann Arbor, MI, USA), 
monolayers were wounded with a single linear scratch twice in both directions and washed 
once with EGF free BEGM with 0.5% (v/v) UG. A dose range of 10 nM to 100 nM NE was 
made in 135 µL EGF free BEGM with 0.5% (v/v) UG and added to appropriate wells. For 
experiments assessing wound repair in the presence of NE inhibited by 1 µM α1AT, 15 µL of 
10 µM α1AT was added 12 hours post wounding to achieve a final concentration of 1 µM. 
Alternatively, 15 µL of EGF free BEGM with 0.5% (v/v) UG was added as media control. 
Cultures were incubated at 37ºC and scratch area was monitored using an IncuCyte live-cell 
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imaging system (Essen Bioscience, Ann Arbor, MI, USA), with wound closure calculated by 
identification of cellular confluence through image analysis and comparing to that of the 
originally created wound area. After 72 hours incubation, cell supernatants were retained at -
80ºC and the monolayer was washed once with serum-free clear RPMI 1640 before MTS 
assay was performed. Results were standardised as a percentage of control.  
 
Assessment of bronchiectasis 
Scans were scored for bronchiectasis with no prior knowledge of child’s health using a 
modified Brodie score as previously described (E10). Bronchiectasis was then identified as a 
bronchus-to-artery ratio of more than one and scoring the extent in each lobe as zero, one or 
two for no observable bronchiectasis, <50% of visible airways and >50% visible airways 
respectively. The maximum score for a scan was 12.  
 
Assessment of neutrophil elastase  
Free NE activity was assessed using an quantitative adapted assay (E11) as previously 
described (E1, E2). Briefly, BAL fluid (BALf) supernatant was serially diluted 1:2 with 0.2 
M Tris buffer pH 8 in duplicate. Tris buffer was also used as the negative control and to 
dilute the human neutrophil elastase standard, serially diluted from 25 µg/mL (847.5 nM) to 
0.02 µg/mL (0.7 nM). Substrate N-methoxysuccinyl Ala-Ala-Pro-Val p-nitroanilide was 
dissolved in N-methyl-2-pyrrolidone to a final concentration of 100 mM, then added to each 
well. Free NE activity cleaves 4-nitroaniline from the substrate, increasing absorbance at 405 
nM. Absorbance was read immediately after substrate addition and again after 20, 30 and 40 
minutes incubation at 37ºC. The time point with the best standard curve according to r-value, 
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typically 40 minutes, was taken to determine activity and results were calculated using 
AssayZap (Biosoft, Cambridge, UK). The lower limit of detection for this assay was 0.2 
µg/mL (6.8 nM). A sample from a separate subject with known elevated NE levels was used 
as an inter-assay positive control and the inter-assay coefficient of variation was previously 
established at 7.99% (E1). 
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Sample
 Age (years) Sex CFTR Genotype CFTR Class* 
Neutrophil 
Elastase (nM) 
Bronchiectasis (0 – 12)
† 
Respiratory Pathogens
‡
 
1 4.25 F p.Phe508del / p.Arg117His 2 / 4 N.D. 0 Mixed oral flora, Staphylococcus aureus 
2 4.63 F p.Phe508del / p.Ile336SerfsX28 2 / 1 N.D. 0 Stenotrophomonas maltophilia 
3 4.45 F p.Arg553X / c.1367T>C 1 / - N.D. 0 N.D. 
4 6.42 M p.Phe508del / c.1585-1G>A 2 / 1 N.D. 2 N.D. 
5 5.09 F p.Phe508del / p.Gly27X 2 / 1 N.D. 1 Stenotrophomonas maltophilia 
6 1.34 F p.Phe508del / c.3367G 2 / - N.D. 0 N.D. 
7 1.97 M p.Phe508del / Unknown 2 / - N.D. 1 Pseudomonas aeruginosa 
8 3.94 F p.Phe508del / p.Gly551Asp 2 / 3 N.D. 0 N.D. 
9 5.30 M p.Phe508del / c.2657+2 3insA 2 / - N.D. 0 N.D. 
10 6.16 F p.Phe508del / p.Arg347Pro 2 / 4 30.17 1 Aspergillus flavus, Aspergillus fumigatus 
11 5.16 M p.Phe508del / c.2657+5G>A 2 / 5 N.D. 1 N.D. 
12 4.94 F p.Phe508del / p.Gly551Asp 2 / 3 N.D. 1 N.D. 
13 6.18 F p.Phe508del / p.Lys447ArgfsX2 2 / - 411.86 1 N.D. 
14 6.16 M p.Phe508del / c.2657+5G>A 2 / 5 N.D. 2 N.D. 
15 5.96 M p.Phe508del / p.Arg117His 2 / 4 N.D. 0 Haemophilus influenzae 
16 0.27 F p.Phe508del / p.Phe508del 2 / 2 N.D. 0 N.D. 
 
Supplementary Table 1. Demographics of subjects from which pAECCF were obtained. N.D. = none detected. *Only known classes 
reported, †bronchiectasis on CT scan scored blindly by clinical radiologist, ‡pathogen data at time of brushing obtained from clinical assessment 
of BALf. 
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  Total Cohort  BALf with Detectable Free NE*
 
Age years BALf n Mean NE nM ±SD Maximum NE nM  BALf n (% total) Mean Detected NE nM ±SD 
0 – 1 232 20.24 ±63.70 728.17  70 (30.17%) 62.61 ±104.90 
1 – 2 245 37.08 ±207.54 3,000.15  59 (24.08%) 146.38 ±406.49 
2 – 3 202 32.06 ±101.78 1,050.90  63 (31.19%) 98.08 ±164.84 
3 – 4 213 51.49 ±128.84 1,118.70  85 (39.91%) 125.91 ±180.52 
4 – 5 189 43.19 ±109.74 866.15  67 (35.45%) 117.47 ±160.15 
5 – 6 163 63.50 ±171.82 1,186.50  64 (39.26%) 157.64 ±247.19 
6 – 7 94 116.41 ±561.36 5,229.08  38 (40.43%) 284.01 ±862.35 
Total 1,338 46.10 ±201.08 5,229.08  446 (33.33%) 131.51 ±332.44 
       
 
Supplementary Table 2. Free NE activity in the AREST CF early childhood cohort. Free NE activity was routinely measured in BALf 
collected from young children with CF at their annual assessment, using an adapted enzymatic assay. Both mean concentration and prevalence of 
detectable free NE activity increased with age. *Minimum detection limit for NE was 6.78 nM. 
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SUPPLEMENTARY FIGURES 
 
Figure S1: Effect of free NE on cellular morphology of pAECs. Monolayer cultures of 
pAECs were exposed to 100 nM NE for 48 hours and time-lapse phase contrast images 
were collected. Both pAECnon-CF (left column) and pAECCF (right column) monolayers 
demonstrated reduced cellular adhesion, cellular rounding and loss of confluence that 
progressed over 48 hours. Images representative of four separate experiments, shown at 
10x magnification with inset images at 20x. 
 
Figure S2: Effect of free NE on NuLi-1 and CuFi-1 cell confluence and viability. Monolayer 
cultures of hTERT transformed AEC were exposed to NE for 48 hours and then cell 
confluence, viability and cytotoxicity assessed. No change in confluence by NuLi-1 (A) 
and CuFi-1 (B) was observed in response to control media (circles), 10 nM (squares), 50 
nM (triangles) and 100 nM (diamonds) NE. After 48 hours, assessment of viability by 
MTS assay (C) demonstrated that NuLi-1 (open bars) and CuFi-1 (closed bars) cell 
number was not reduced by NE. Nor was a significant change observed in the supernatant 
cytotoxicity marker LDH (D). Data was obtained from two to four separate experiments, 
with each point assessed in quadruplicate. 
 
Figure S3: Effect of free NE on the morphology of proliferating pAECnon-CF. Monolayer 
pAECnon-CF cultures initially seeded at 5,000 cells/well were incubated for 24 hours to 
facilitate attachment and then subsequently exposed to NE over 120 hours. Time-lapse 
phase contrast images were then collected over this period at 2 hourly intervals. 
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Incubation with 100 nM NE resulted in a rounded morphology that indicated loss of 
cellular attachment. Also observed were fewer cell numbers at 120 hours, suggesting 
inhibition of proliferation. Images representative of four separate experiments, shown at 
10x magnification with inset images at 20x. 
 
Figure S4: Effect of free NE on the morphology of proliferating pAECCF. Monolayer 
pAECCF cultures initially seeded at 5,000 cells/well were incubated for 24 hours to 
facilitate attachment, then subsequently exposed to NE over 120 hours. Time-lapse phase 
contrast images were then collected over this period at 2 hourly intervals. Incubation with 
100 nM NE resulted in a rounded morphology that indicated loss of cellular attachment. 
Also observed were fewer cell numbers at 120 hours, suggesting inhibition of 
proliferation. Images representative of four separate experiments, shown at 10x 
magnification with inset images at 20x. 
 
Figure S5: Effect of free NE on NuLi-1 and CuFi-1 cell proliferation.  Monolayer hTERT 
transformed cell cultures initially seeded at 5,000 cells/well were incubated for four hours 
to facilitate attachment and then exposed to NE over 120 hours to assess effect on 
proliferation by measuring changes in confluence. When compared to control (circles), no 
change in confluence was seen by NuLi-1 (A) and CuFi-1 (B) in response to 10 nM 
(squares), 50 nM (triangles) and 100 nM (diamonds) NE. Assessment by MTS assay (C) 
demonstrated no effect on viable cell number of either NuLi-1 (open bars) or CuFi-1 
(closed bars). Data was obtained from four separate experiments, with each point 
performed in triplicate. 
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Figure S6: Effect of α1AT on pAECCF reattachment, resulting proliferation and wound 
repair. Confluent monolayer cultures of pAECCF were wounded with a single linear 
scratch (blue outline) and in the presence of 100 nM NE repair was assessed over 72 
hours (left column), via the acquisition of time-lapse phase contrast images and analysis 
of pAECCF confluence (yellow highlight). At 12 hours post wounding, 1 µM α1AT was 
added certain wells to determine the effect on repair over the remaining 60 hours (right 
column). Data generated showed that, pAECCF treated with 1 µM α1AT progressively 
reattached to the culture vessel and induced significant wound coverage by 24 hours 
(p<0.05). Repair continued to be significantly induced over 72 hours although not to 
completion (p=0.0008). Images taken at 30 hours are representative of four separate 
experiments, shown at 10x magnification. 
 
Figure S7: Effect of free NE on CuFi-1 wound repair. Confluent monolayer cultures of CuFi-
1 were wounded with a single linear scratch and wound repair in the presence of control 
media (circles), 10 nM (squares), 50 nM (triangles) and 100 nM (diamonds) NE assessed. 
Wounded CuFi-1 in control media achieved 100% closure by 40 hours. However, 100 nM 
NE significantly reduced wound closure up to 42 hours post wounding. *indicates 100 
nM NE p<0.05 to control media. Data was collated from two separate experiments, with 
each point performed in quadruplicate. 
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